Uncategorized

Still Here!

Is it really July 21st already?  The summer is flying by and we’ll be back in school looking at Fall before you know it.  I wanted to post a few interesting tidbits for medication dispensing clinics looking at fall medication orders.  Back to school will soon be upon us as well as  another exciting cold & flu season.

Newly approved generic pharmaceuticals:

LEVONORGESTREL TABS (PLAN B) – approved for Watson in June
PRILOSEC OTC DR CAPS – approved for Dr. Reddy’s in June
ORTHO TRI CYCLIN LO – approved for Barr in June
KENALOG 10 AND KENALOG 40 – approved for Sandoz in May and June

Though prices won’t drop immediately, as new generics get into the market, prices will slowly begin to come down.  Feel free to call PCA at 800.722.0772 to check on any specific products.

Some antibiotic products are still a bit high as the market recovers from recalls and product discontinuations.  We are keeping our eye on these products and will continue to advise our clinic partners on their options.  The good news is that the FDA has recently approved the 2009-2010 flu vaccine and they expect to have an H1N1 vaccine by fall.

Student health centers evaluating fall ordering are invited to contact PCA Pharmaceuticals for a comparative price quotation.  PCA is your partner for all of your clinic dispensing needs.

Schedule a free claims analysis now.

Let’s Talk now

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading